When President Donald Trump declared in May that he wanted drug companies to voluntarily cut their prices, few pharmaceutical ...

Today, the New York State Emerging Technology Advisory Board (ETAB) released its final report of recommendations to Governor ...

The Trump administration on Friday announced deals with nine drugmakers aimed at lowering pharmaceutical prices, bringing its total number of drug-pricing agreements to 14.

BioMarin said it is acquiring Amicus Therapeutics, maker of rare-disease drugs, for $4.8 billion. A new FDA program meant to ...

Pfizer Inc. (NYSE:PFE)’s shares are down by 5.90% year-to-date, and December has been a tumultuous month for them.

We recently published 12 Stocks on Jim Cramer’s Radar . Merck & Co., Inc. (NYSE:MRK) is one of the stocks on Jim Cramer’s ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

In today’s Pharmaceutical Executive Daily, Pfizer discloses its 2026 revenue expectations, a bipartisan group of House ...

Now there is evidence that Hympavzi is also effective for people with hemophilia A and B who have developed inhibitors, a ...